Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know
Portfolio Pulse from
Wall Street analysts predict a significant upside of 127.3% for Benitec Biopharma (BNTC) based on average price targets. Positive earnings estimate revisions could support this potential increase.
February 20, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wall Street analysts have set an average price target for Benitec Biopharma (BNTC) indicating a potential upside of 127.3%. This is supported by positive trends in earnings estimate revisions.
The article highlights a significant potential upside for BNTC based on analyst price targets and positive earnings estimate revisions. This suggests a likely positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100